Inflammation & Wound Healing
🟢 Lite — Quick Review (1h–1d)
Rapid summary for last-minute revision before your exam.
Acute inflammation (<24 hrs): Neutrophils, vasodilation, increased vascular permeability → heat, redness, swelling, pain, loss of function. Cardinal signs: Rubor (redness), calor (heat), tumor (swelling), dolor (pain), functio laesa (loss of function).
Chronic inflammation (days–weeks): Lymphocytes, macrophages, plasma cells; tissue destruction + fibrosis; granuloma formation.
Wound healing:
- 1st intention: Clean surgical incision; minimal tissue loss; sutured; minimal scarring
- 2nd intention: Large tissue loss; healing from wound edges + base; granulation tissue; significant scar
- 3rd intention: Wound approximated but infected; healing by secondary intention
Types of healing: Regeneration (hepatocytes, epithelium) vs fibrosis/scarring (connective tissue).
⚡ Exam tip: “Granuloma with caseous necrosis” = TB. “Granuloma with asteroid bodies” = sarcoidosis. “Granuloma with schistosome eggs” = schistosomiasis.
🟡 Standard — Regular Study (2d–2mo)
Standard content for students with a few days to months.
Acute Inflammation
Steps
- Vasodilation (immediate, transient): Histamine, bradykinin, NO → arterioles dilate → redness (rubor) and heat (calor); mediated by histamine and prostaglandins
- Increased vascular permeability (immediate or delayed):
- Immediate transient: Histamine, bradykinin → endothelial cell contraction (widens intercellular gaps) → leak in venules (1–5 µm); lasts 15–30 min
- Immediate sustained: Severe injury (burns, toxins) → direct endothelial damage → leakage from all vessels
- Delayed sustained: Cytokines (IL-1, TNF-α, VEGF) → endothelial cell contraction → leak in venules and capillaries; takes 4–6 hours
- Leukocyte extravasation: Rolling → adhesion → transmigration → chemotaxis
- Phagocytosis: Opsonization (IgG, C3b), recognition, engulfment, killing
Leukocyte Extravasation Sequence
- Margination: Leukocytes move to periphery of vessel
- Rolling: Selectins (E-selectin, P-selectin) on endothelium bind carbohydrates on leukocytes → transient adhesion → leukocytes “roll”
- Adhesion: Tight adhesion; ICAM-1, VCAM-1 on endothelium bind integrins (LFA-1 = CD11a/CD18; Mac-1 = CD11b/CD18) on leukocytes
- Transmigration (diapedesis): Leukocytes squeeze between endothelial cells; CD31 (PECAM-1) on both leukocytes and endothelium facilitates this
- Chemotaxis: Directed migration along chemical gradient; neutrophil attractants: bacterial products (N-formyl peptides), C5a, IL-8 (CXCL8), LTB4
Phagocytosis & Killing
Opsonization: IgG (Fab fragment binds antigen, Fc binds Fc receptor on neutrophils/macrophages), C3b (complement opsonin)
Killing mechanisms:
- Oxygen-dependent (respiratory burst):
- NADPH oxidase generates superoxide (O₂⁻) → dismutates to H₂O₂
- Myeloperoxidase (MPO) in neutrophils: H₂O₂ + Cl⁻ → HOCl (hypochlorous acid, bleach) → potent microbicide
- Chronic Granulomatous Disease (CGD): Defect in NADPH oxidase → catalase-positive organisms (S. aureus, Aspergillus, Serratia, Nocardia, Burkholderia cepacia — mnemonic: “PLACESS”) cannot be killed
- Nitroblue tetrazolium (NBT) test: Negative in CGD (no respiratory burst → no formazan blue color)
- Oxygen-independent: Lysozyme, lactoferrin, defensins, bactericidal permeability-increasing protein (BPI)
Neutrophil vs Monocyte/Macrophage
| Feature | Neutrophils | Macrophages |
|---|---|---|
| First response | <6–12 hours | 24–48 hours |
| Lifespan | Short (hours–days) | Long (months–years) |
| Primary role | Phagocytosis of bacteria | Phagocytosis of debris, chronic inflammation |
| Key enzymes | Myeloperoxidase | Lysosomal acid hydrolases |
| Not in healing | No role in tissue repair | Activate fibroblasts → fibrosis |
Chronic Inflammation
Causes
- Persistent infections: TB, syphilis, viral infections, fungal infections
- Autoimmune diseases: Rheumatoid arthritis, SLE, IBD
- Prolonged exposure to toxic agents: Silica (silicosis), asbestos (asbestosis), hydrocarbons
- Transplant rejection
Histologic Features
- Infiltration by lymphocytes, plasma cells, macrophages (mononuclear infiltrate)
- Tissue destruction (by inflammatory cells)
- Fibrosis/scarring (attempted repair)
- Angiogenesis (new blood vessel formation; VEGF mediated)
Granulomatous Inflammation
Granuloma: Collection of epithelioid macrophages (activated macrophages with abundant pink cytoplasm) ± giant cells + lymphocytes + fibroblasts
Types of granulomas:
- Foreign body granuloma: Non-immune; response to inert foreign material (suture, silica, asbestos, urate crystals, cholesterol crystals); giant cells are Langhans type (peripheral nuclei) but differ from TB granulomas
- Immune granuloma: Type IV hypersensitivity; poorly degradable antigen persists → T cell-mediated (IFN-γ from CD4+ Th1 cells activates macrophages)
Key Examples:
- TB granuloma (caseating granuloma): Central caseous necrosis + epithelioid cells + Langhans giant cells (horseshoe nuclei) + peripheral lymphocytes + fibroblasts; contains M. tuberculosis (AFB may be scanty)
- Sarcoidosis: Non-caseating granulomas + asteroid bodies (eosinophilic inclusions in giant cells) + Schaumann bodies (laminated calcified concretions); bilateral hilar lymphadenopathy; lung involvement
- Crohn disease: Non-caseating granulomas; transmural inflammation; skip lesions
- Schistosomiasis: Granulomas with schistosome eggs; pipestem fibrosis (Symmers fibrosis)
- Cat-scratch disease: CSD granuloma with necrotizing stellate abscesses; Bartonella henselae
- Leprosy: Tuberculoid (paucibacillary, Th1 response, good immunity) vs Lepromatous (multibacillary, poor Th1 response, widespread disease)
Wound Healing
Phases of Wound Healing
- Hemostasis (immediate): Platelet plug + fibrin clot; platelet-derived growth factor (PDGF) released
- Inflammatory phase (Day 1–3):
- Neutrophils predominate (first 24–48 hours); remove bacteria, debris
- Macrophages appear by day 2–3; key cells for wound healing (secrete cytokines: IL-1, TNF-α, growth factors)
- Lymphocytes appear by day 3–5
- Proliferative phase (Day 3–3 weeks):
- Granulation tissue: Fibroblasts + new blood vessels (angiogenesis, mediated by VEGF and FGF) + Type III collagen
- Angiogenesis: Formation of new blood vessels from existing vessels; VEGF is key mediator
- Fibroblasts: Migrate into wound; produce extracellular matrix (Type III collagen initially)
- Myofibroblasts: Wound contraction (TGF-β mediated)
- Epithelialization: Re-epithelialization from wound edges; basal cells migrate across wound bed; contact inhibition when confluence reached
- Remodeling/Maturation (3 weeks–1–2 years):
- Type III collagen → Type I collagen (scar strengthening)
- Wound tensile strength: 3% at 1 week, 30% at 3 weeks, 80% at 3 months (max)
- Scar: Pale, avascular, acellular; mature scar has Type I collagen (organized)
Factors Affecting Wound Healing
Local: Infection (most important), hypoxia (poor blood supply), radiation, denervation, foreign bodies, mechanical forces
Systemic: Age (elderly = slower), nutrition (protein, vitamin C, zinc), diabetes mellitus (impaired healing + increased infection), steroids (inhibit inflammation and fibroblast function), immunosuppression, smoking (vasoconstriction → hypoxia), malignancy
Complications of Wound Healing
- Infection: Most common complication; purulent discharge
- Dehiscence: Surgical wound breakdown; risk factors: wound infection, poor surgical technique, increased intra-abdominal pressure
- Hypertrophic scar: Raised scar within wound boundaries; more common in children, burns; regresses partially
- Keloid: Raised scar that extends beyond wound boundaries; more common in dark-skinned individuals; familial; Tx: intralesional steroids, pressure therapy, radiotherapy; RECURS despite treatment
- Contractures: Scarring that shortens tissue; most common after burns; limits joint movement
- Adhesions: Fibrous bands between serosal surfaces; most common in peritoneal cavity after surgery or peritonitis
Wound Strength
- Day 0: Tensile strength = 0 (transected)
- Week 1: ~3% (fibrin clot)
- Week 3: ~30% (Type III collagen cross-linking)
- Month 3: ~80% (Type I collagen replaces Type III; remodeling)
- Scar never reaches >80% of original tissue strength
🔴 Extended — Deep Study (3mo+)
Comprehensive coverage for students on a longer study timeline.
Chemical Mediators of Inflammation
Vasoactive Amines
- Histamine: Stored in mast cells, basophils, platelets; released by IgE-mediated degranulation, complement (C3a, C5a), physical injury
- Actions: Vasodilation (H2 receptors), increased vascular permeability (H1 receptors → endothelial cell contraction), itch, pain
- Serotonin (5-HT): Platelets, enterochromaffin cells; vasoconstriction at high doses; vasodilation at low doses; potentiates platelet aggregation
Arachidonic Acid Metabolites
- Cyclooxygenase (COX) pathway → Prostaglandins (PGD₂, PGE₂, PGF₂α, PGI₂ = prostacyclin) and Thromboxane A₂ (TXA₂)
- PGE₂: Vasodilation, fever, pain, protects gastric mucosa
- PGI₂ (prostacyclin): Vasodilation, inhibits platelet aggregation (produced by endothelium)
- TXA₂: Vasoconstriction, promotes platelet aggregation (produced by platelets)
- Aspirin: Irreversibly inhibits COX-1 and COX-2 → ↓TXA₂ (antiplatelet) + ↓PGI₂ (both lost; net effect = antiplatelet); gastric ulceration (lost PGE₂ protection)
- Lipoxygenase (LOX) pathway → Leukotrienes (LTB₄, LTC₄, LTD₄, LTE₄)
- LTB₄: Potent neutrophil chemotaxis
- LTC₄, LTD₄, LTE₄: Bronchoconstriction, increased vascular permeability, mucus secretion (components of slow-reacting substance of anaphylaxis, SRS-A)
Cytokines
- IL-1: Fever (acts on hypothalamus → ↑COX → ↑PGE₂), acute phase reactants, endothelial activation
- TNF-α: Fever, cachexia, endothelial activation, shock, neutrophil recruitment
- IL-6: Acute phase reactants (hepatocytes → CRP, fibrinogen, serum amyloid A)
- IL-8 (CXCL8): Neutrophil chemotaxis (major chemokine for neutrophils)
Complement System
- C3a, C5a (anaphylatoxins): Mast cell degranulation → histamine release → vasodilation + increased permeability
- C3b: Opsonization (most important opsonin)
- C5a: Neutrophil chemotaxis + activation
- MAC (membrane attack complex): C5b–C9 → creates pores in bacterial cell membrane → lysis
Kinin System
- Bradykinin: Vasodilation, increased vascular permeability, pain (slow-acting), causes bronchoconstriction
- Generated from kininogen by kallikrein (activated by Hageman factor = Factor XII)
- Aspirin/NSAIDs inhibit bradykinin generation (part of their anti-inflammatory effect)
Nitric Oxide (NO)
- Produced by endothelial nitric oxide synthase (eNOS) → vasodilation; Anti-inflammatory (inhibits platelet aggregation, leukocyte adhesion)
- Produced by inducible nitric oxide synthase (iNOS) during inflammation → antimicrobial (reactive nitrogen species)
Healing of Specific Tissues
Liver Regeneration
- Hepatocytes can divide (quiescent → proliferate); can regenerate up to 70% of liver mass
- Oval cells (bipotent progenitor cells) activate when hepatocyte proliferation is impaired
- Liver architecture restored without scarring (if basement membrane is intact)
- Repeated injury → cirrhosis (fibrosis + regenerative nodules = regenerative failure)
Bone Healing
- Inflammatory phase: Hematoma formation between fracture ends; inflammatory infiltrate
- Soft callus formation (Days 7–14): Fibroblasts + chondrocytes produce Type II collagen (cartilaginous callus)
- Hard callus formation (Weeks 3–12): Osteoblasts produce woven bone (Type I collagen + hydroxyapatite); bridging callus
- Remodeling: Woven bone → lamellar bone; restored architecture
Myocardial Infarction Healing
- 0–4 hours: No visible changes; wavy fibers
- 4–12 hours: Early coagulative necrosis; edema; marginal RBC extravasation
- 12–24 hours: Coagulative necrosis begins; pyknosis, early neutrophil infiltration
- 1–3 days: Loss of nuclei; heavy neutrophil infiltration; yellow softening
- 3–7 days: Macrophages arrive; disintegration of dead myocytes; early granulation tissue at margins
- 1–3 weeks: Granulation tissue (capillaries + fibroblasts + macrophages); red, soft
- Weeks to months: Progressive fibrosis; grey-white scar tissue (dense collagen)
Nerve Regeneration
- CNS (brain, spinal cord): NO significant regeneration; oligodendrocytes produce inhibitory proteins (Nogo, MAG); glial scar
- PNS: Axons can regenerate; Schwann cells proliferate; Büngner bands guide regrowth; functional recovery possible if gap is small
Chronic Inflammation & Cancer
- Chronic irritation/inflammation → DNA damage → mutations → cancer (part of inflammation-oncology link)
- Examples: Chronic UC → colorectal cancer; chronic pancreatitis → pancreatic cancer; H. pylori → gastric cancer; chronic hepatitis B/C → hepatocellular carcinoma; asbestos → mesothelioma + lung cancer; schistosomiasis (S. haematobium) → bladder cancer
Key NEET PG Pearls
- Cardinal signs of inflammation: Rubor (redness), calor (heat), tumor (swelling), dolor (pain), functio laesa (loss of function)
- Neutrophils arrive first (<24 hrs); macrophages by day 2–3; lymphocytes by day 3–5
- VEGF is the key growth factor for angiogenesis; PDGF is key for fibroblast proliferation
- C3b = most important complement opsonin; C5a = neutrophil chemotaxis and activation
- LTB₄ = potent neutrophil chemotactic factor (arachidonic acid via 5-lipoxygenase)
- Granuloma with central caseous necrosis + Langhans giant cells = TB
- Granuloma with asteroid bodies = Sarcoidosis; Schaumann bodies also seen
- CGD: Defective NADPH oxidase → catalase-positive organisms; negative NBT test
- Keloid: Extends beyond wound margins; dark-skinned individuals; recurrent; Hypertrophic scar: Within margins
- Type III collagen → Type I collagen remodeling = wound strengthening; tensile strength never exceeds 80% of original
Content adapted based on your selected roadmap duration. Switch tiers using the selector above.